-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Levothyroxine in Hypothyroidism
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Levothyroxine in Hypothyroidism report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – INS-3001 in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - INS-3001 in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.INS-3001 in Peripheral Arterial Disease (PAD)/ Peripheral...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Patiromer Sorbitex Calcium in Resistant Hypertension
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Patiromer Sorbitex Calcium in Resistant HypertensionDrug Details:Patiromer sorbitex calcium (RLY5016, Veltassa) is a cross-linked polymer of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sirolimus in Lymphangioleiomyomatosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus in Lymphangioleiomyomatosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sirolimus in Lymphangioleiomyomatosis Drug Details: Sirolimus is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SNF-472 in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SNF-472 in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SNF-472 in Peripheral Arterial Disease (PAD)/ Peripheral...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SNF-472 in Arterial Calcification
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SNF-472 in Arterial Calcification report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SNF-472 in Arterial Calcification Drug Details: SNF-472 (hexasodium phytate) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Batoclimab in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Batoclimab in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Batoclimab in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Drug...
-
Sector Analysis
Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2023 Edition
Contract Pharmaceutical Dose Manufacturing Industry Overview The total dose CMO contract revenue in 2022 represented significant growth over 2021 revenue. The growth rate was the highest recorded since 2011 for commercial contract dose manufacturing revenues, and surprisingly adds to the strong growth experienced in 2021, despite demand for COVID-19 vaccines and therapies waning in 2022. The Contract Pharmaceutical Dose Manufacturing Industry report is a comprehensive look at the finished dose contract manufacturing landscape in 2023. It includes an analysis of...